Literature DB >> 7917856

Insulin and growth in chronic renal failure.

R H Mak1, G B Haycock, C Chantler.   

Abstract

We studied glucose metabolism using the hyperglycemic technique in a cross-section of 23 children (15 pubertal, 8 prepubertal) with stable chronic renal failure as a possible cause of their poor growth. Linear growth was expressed as growth velocity standard deviation score (GVSDS). GVSDS correlated with glucose disposal rate but not with insulin sensitivity index in the pubertal (r = 0.87, P < 0.001) and prepubertal (r = 0.86, P < 0.02) children with chronic renal failure. Thirteen children were followed longitudinally during medical suppression of hyperparathyroidism with dietary phosphate restriction and high-dose phosphate binders. Following significant suppression of serum parathyroid hormone (PTH) levels back to the normal range (932 +/- 240 ng/l to 199 +/- 50 ng/l), GVSDS, glucose disposal rate and insulin secretion all increased significantly (p < 0.01), with no change in insulin sensitivity index and renal function. The changes in GVSDS correlated with the changes in glucose disposal rate (r = 0.86, P < 0.02) and with the changes in insulin secretion (r = 0.80, P < 0.01). However, the changes in GVSDS did not correlate with the changes in PTH. The hypothesis that insulin may be more important than PTH in the pathogenesis of growth failure in chronic renal disease deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917856     DOI: 10.1007/bf00866344

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

1.  Insulin as a growth hormone.

Authors:  J SALTER; C H BEST
Journal:  Br Med J       Date:  1953-08-15

Review 2.  New concepts in insulin-like growth factor receptor physiology.

Authors:  Y Oh; H L Müller; E K Neely; G Lamson; R G Rosenfeld
Journal:  Growth Regul       Date:  1993-06

3.  Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid.

Authors:  C Chantler; T M Barratt
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

4.  Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin.

Authors:  R A DeFronzo; J D Tobin; J W Rowe; R Andres
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

5.  Secondary hyperparathyroidism and glucose intolerance in children with uremia.

Authors:  R H Mak; C Turner; G B Haycock; C Chantler
Journal:  Kidney Int Suppl       Date:  1983-12       Impact factor: 10.545

6.  Glucose intolerance in children with chronic renal failure.

Authors:  R H Mak; G B Haycock; C Chantler
Journal:  Kidney Int Suppl       Date:  1983-11       Impact factor: 10.545

7.  Long-term suppression of hyperparathyroidism by phosphate binders in uremic children.

Authors:  K Tamanaha; R H Mak; S P Rigden; C Turner; K M Start; G B Haycock; C Chantler
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

8.  Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide.

Authors:  R H Mak; C Turner; T Thompson; H Powell; G B Haycock; C Chantler
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-07

9.  Effect of intensive insulin treatment on linear growth in the young diabetic patient.

Authors:  M C Rudolf; R S Sherwin; R Markowitz; S E Bates; M Genel; J Hochstadt; W V Tamborlane
Journal:  J Pediatr       Date:  1982-09       Impact factor: 4.406

10.  Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity.

Authors:  S Caprio; G Plewe; M P Diamond; D C Simonson; S D Boulware; R S Sherwin; W V Tamborlane
Journal:  J Pediatr       Date:  1989-06       Impact factor: 4.406

View more
  2 in total

Review 1.  Diets and enteral supplements for improving outcomes in chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Noël J Cano; Klemens Budde; Charles Chazot; Csaba P Kovesdy; Robert H Mak; Rajnish Mehrotra; Dominic S Raj; Ashwini R Sehgal; Peter Stenvinkel; T Alp Ikizler
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

Review 2.  Lipoprotein metabolism in chronic renal insufficiency.

Authors:  Jeffrey M Saland; Henry N Ginsberg
Journal:  Pediatr Nephrol       Date:  2007-03-28       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.